Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The mean half-life of antipyrine in the plasma of four sets of identical and four sets of fraternal twins after a single oral dose of 16 mg/kg of antipyrine was 12.7 +/-(SD) 3.3 hr. After 2 wk on sodium phenobarbital (2 mg/kg daily) the half-life of antipyrine in the plasma of these twins was reduced to 8.0 +/-(SD) 1.5 hr. Shortening of the plasma antipyrine half-life occurred in all but one of these 16 normal, adult volunteers, but there was considerable variation in the extent of reduction which ranged from 0 to 69%. Phenobarbital administration decreased individual variations in antipyrine metabolism as indicated by the smaller standard deviation of the plasma antipyrine half-lives after phenobarbital than observed initially and by the narrowed range of variation in plasma antipyrine half-lives from 2.8-fold initially to 1.8-fold after phenobarbital. These results suggest that some inducing agents may be used to minimize individual variations in drug metabolism where such variations create therapeutic problems by exposing patients who slowly metabolize certain drugs to toxicity and other patients who rapidly metabolize some drugs to undertreatment. During the course of phenobarbital administration blood levels were determined. Phenobarbital blood levels correlated neither with the final values for plasma antipyrine half-lives nor with the per cent reduction in plasma antipyrine half-life produced by phenobarbital treatment. There was a direct relationship between initial antipyrine half-lives and the per cent shortening of antipyrine half-life produced by phenobarbital administration: the shorter the initial antipyrine half-life, the less the reduction caused by phenobarbital treatment. Larger intrapair variances in fraternal than in identical twins indicate genetic, rather than environmental, control of phenobarbital-induced alterations in plasma antipyrine half-life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PHARMACOLOGICAL IMPLICATIONS OF MICROSOMAL ENZYME INDUCTION
CONNEY, A. H. (1967) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07146-7 · Cited by 2,951
THE ESTIMATION OF ANTIPYRINE IN BIOLOGICAL MATERIALS
Brodie, B. B., Axelrod, J., Soberman, R., & Levy, B. B. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56807-1 · Cited by 409
THE USE OF ANTIPYRINE IN THE MEASUREMENT OF TOTAL BODY WATER IN MAN
Soberman, R., Brodie, B. B., Levy, B. B., Axelrod, J., Hollander, V., & Steele, J. M. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56808-3 · Cited by 362
Yaffe, S. J., Levy, G., Matsuzawa, T., & Baliah, T. (1966) · New England Journal of Medicine · doi:10.1056/nejm196612292752602 · Cited by 261
Cucinell, S. A., Conney, A. H., Sansur, M., & Burns, J. J. (1965) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196564420 · Cited by 236
Brodie, B. B., & Axelrod, J. (1950) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03534-7 · Cited by 226
Genetic Control of Drug Levels in Man: Antipyrine
Vesell, E. S., & Page, J. G. (1968) · Science · doi:10.1126/science.161.3836.72 · Cited by 220
Self-citationGenetic control of dicumarol levels in man
Vesell, E. S., & Page, J. G. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105949 · Cited by 153
Self-citationCrigler, J. F., & Gold, N. I. (1969) · Journal of Clinical Investigation · doi:10.1172/jci105973 · Cited by 95
The effect of caffeine on drug metabolism
Mitoma, C., Sorich, T. J., & Neubauer, S. E. (1968) · Life Sciences · doi:10.1016/0024-3205(68)90328-7 · Cited by 49
Cited by
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
The Stereoselective Interaction of Warfarin and Metronidazole in Man
O'Reilly, R. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950702 · Cited by 209
In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone
McCune, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110215 · Cited by 162
“Of note, this observation was initially reported by Vesell et a”
ResultInteractions between anticonvulsants and other commonly prescribed drugs
Kutt, H. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb05644.x · Cited by 77
The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man
OHNHAUS, E. E., BÜRGI, H., BURGER, A., & STUDER, H. (1981) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1981.tb02000.x · Cited by 50
Metadata
- Authors
- Veseli, E. S., & Page, J. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1969-12-01
- Volume
- 48
- Issue
- 12
- Pages
- 2202-2209
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1965877169
- Cited by
- 223
- References
- 10
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.